Anti-alpha2 integrin antibodies and their uses

Details for Australian Patent Application No. 2011219496 (hide)

Owner Glenmark Pharmaceuticals S.A.

Inventors Blein, Stanislas; Hou, Samuel; Skegro, Darko

Agent Watermark

Pub. Number AU-A-2011219496

PCT Pub. Number WO2011/104604

Priority 61/307,009 23.02.10 US

Filing date 22 February 2011

Wipo publication date 1 September 2011

International Classifications

C07K 16/28 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

27 September 2012 PCT application entered the National Phase

  PCT publication WO2011/104604 Priority application(s): WO2011/104604

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011219524-Immunogenic proteins and compositions

2011219494-A porous ABPBI (Phosphoric Acid Doped Poly (2,5-benzimidazole)) membrane and process of preparing the same